Patents Assigned to Jiangsu Cdymax Pharmaceuticals Co., Ltd.
  • Patent number: 9522934
    Abstract: Provided are acetaic abiraterone trifluoroacetate, a preparation method and an application of same. The acetaic abiraterone trifluoroacetate is obtained through a salt-forming reaction between acetaic Abiraterone and trifluoroacetic acid. The acetaic abiraterone trifluoroacetate undergoes self-purification through recrystallization, and dissociation and recrystallization are performed on the purified abiraterone acetate trifluoroacetate, so that the obtained acetaic abiraterone has a high purity, a high yield and stable quality, and is capable of meeting the requirement for mass production of acetaic abiraterone.
    Type: Grant
    Filed: February 20, 2013
    Date of Patent: December 20, 2016
    Assignees: Shanghai Cdymax Pharmaceuticals Co., Ltd., Jiangsu Cdymax Pharmaceuticals Co., Ltd., Shanghai Acebright Pharmaceuticals Group Co., Ltd.
    Inventors: Xiaoxia An, Chengjun Huang, Fengwang Mao